ZIOPHARM Oncology, Inc. (ZIOP) Is At $4.48 Formed Wedge; Aqr Capital Management Boosted By $867,888 Its Verint Sys (VRNT) Holding

Verint Systems Inc. (NASDAQ:VRNT) Logo

ZIOPHARM Oncology, Inc. (ZIOP) formed wedge down with $4.08 target or 9.00% below today’s $4.48 share price. ZIOPHARM Oncology, Inc. (ZIOP) has $631.58M valuation. The stock decreased 3.86% or $0.18 during the last trading session, reaching $4.48. About 848,776 shares traded. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) has declined 39.46% since April 16, 2017 and is downtrending. It has underperformed by 51.01% the S&P500.

Aqr Capital Management Llc increased Verint Sys Inc (VRNT) stake by 22.75% reported in 2017Q4 SEC filing. Aqr Capital Management Llc acquired 21,168 shares as Verint Sys Inc (VRNT)’s stock declined 9.93%. The Aqr Capital Management Llc holds 114,201 shares with $4.78M value, up from 93,033 last quarter. Verint Sys Inc now has $2.61 billion valuation. The stock decreased 0.37% or $0.15 during the last trading session, reaching $40.8. About 186,050 shares traded. Verint Systems Inc. (NASDAQ:VRNT) has declined 5.87% since April 16, 2017 and is downtrending. It has underperformed by 17.42% the S&P500.

Among 4 analysts covering Ziopharm Oncology (NASDAQ:ZIOP), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Ziopharm Oncology has $9.5 highest and $6 lowest target. $8.25’s average target is 84.15% above currents $4.48 stock price. Ziopharm Oncology had 9 analyst reports since December 4, 2015 according to SRatingsIntel. H.C. Wainwright maintained ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) on Monday, March 5 with “Buy” rating. On Wednesday, August 10 the stock rating was upgraded by Wells Fargo to “Market Perform”. On Monday, January 25 the stock rating was maintained by Mizuho with “Neutral”. The stock of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) has “Neutral” rating given on Wednesday, May 11 by Mizuho. The rating was initiated by Wells Fargo with “Underperform” on Friday, December 4. The firm has “Buy” rating given on Thursday, December 14 by H.C. Wainwright. The stock has “Market Perform” rating by Raymond James on Thursday, June 2.

Analysts await ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) to report earnings on May, 7. They expect $-0.13 EPS, up 13.33% or $0.02 from last year’s $-0.15 per share. After $-0.13 actual EPS reported by ZIOPHARM Oncology, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Investors sentiment decreased to 1.22 in 2017 Q4. Its down 0.25, from 1.47 in 2017Q3. It turned negative, as 32 investors sold VRNT shares while 57 reduced holdings. 33 funds opened positions while 76 raised stakes. 59.15 million shares or 3.05% more from 57.40 million shares in 2017Q3 were reported. Pub Employees Retirement Systems Of Ohio accumulated 2,417 shares or 0% of the stock. State Street Corp accumulated 1.30 million shares. Geode Management Limited Com owns 588,786 shares or 0.01% of their US portfolio. Schafer Cullen Cap Mngmt Inc stated it has 0.01% of its portfolio in Verint Systems Inc. (NASDAQ:VRNT). Proshare Llc holds 0% of its portfolio in Verint Systems Inc. (NASDAQ:VRNT) for 12,121 shares. First Personal Fincl accumulated 222 shares. Pub Employees Retirement Association Of Colorado stated it has 10,035 shares. Impax Asset Mgmt Ltd owns 420,000 shares for 1.01% of their portfolio. Etrade Cap Management Llc has invested 0.02% in Verint Systems Inc. (NASDAQ:VRNT). Quantbot Tech Ltd Partnership holds 0.02% or 4,208 shares. Jacobs Levy Equity Mgmt holds 204,048 shares. Prudential Fincl Incorporated has invested 0.02% in Verint Systems Inc. (NASDAQ:VRNT). Cornercap Counsel has 0.11% invested in Verint Systems Inc. (NASDAQ:VRNT). Arrowgrass Partners (Us) Ltd Partnership holds 0.05% or 133,800 shares. Rbf Capital Ltd Llc holds 0.09% or 20,000 shares in its portfolio.

Among 9 analysts covering Verint Systems (NASDAQ:VRNT), 6 have Buy rating, 1 Sell and 2 Hold. Therefore 67% are positive. Verint Systems had 32 analyst reports since September 3, 2015 according to SRatingsIntel. The firm has “Buy” rating by RBC Capital Markets given on Sunday, October 22. The firm has “Outperform” rating given on Thursday, September 3 by Credit Suisse. The stock has “Hold” rating by Imperial Capital on Friday, June 9. The company was maintained on Friday, September 9 by Imperial Capital. The firm has “Buy” rating given on Monday, September 18 by RBC Capital Markets. Credit Suisse downgraded Verint Systems Inc. (NASDAQ:VRNT) on Wednesday, March 30 to “Underperform” rating. William Blair upgraded the stock to “Outperform” rating in Tuesday, September 29 report. Deutsche Bank maintained Verint Systems Inc. (NASDAQ:VRNT) on Thursday, December 3 with “Buy” rating. The stock of Verint Systems Inc. (NASDAQ:VRNT) has “Outperform” rating given on Thursday, October 8 by Imperial Capital. The stock of Verint Systems Inc. (NASDAQ:VRNT) has “Hold” rating given on Thursday, September 7 by Deutsche Bank.

Aqr Capital Management Llc decreased Healthcare Rlty Tr (NYSE:HR) stake by 49,647 shares to 180,622 valued at $5.80 million in 2017Q4. It also reduced Nacco Inds Inc (NYSE:NC) stake by 46,955 shares and now owns 8,369 shares. Heartland Finl Usa Inc (NASDAQ:HTLF) was reduced too.

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Institutional Positions Chart